Abbott Laboratories (ABT)
$103.72
1.69 (1.66%)
ABT Stock Quote Delayed 30 Minutes
Hottest Healthcare Stocks Now – RMD COO AGN NEOG
Healthcare stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 0.6%. NYSE:RMD, NYSE:COO, NYSE:AGN, NASDAQ:NEOG, NYSE:DGX, NASDAQ:UTHR, NYSE:ABT, NYSE:SEM, NYSE:HAE, NYSE:EXAM, NASDAQ:ACAD, NASDAQ:INCY, NYSE:LCI, NYSE:PBYI, NASDAQ:CBST, NASDAQ:QCOR, NASDAQ:CLDX, NASDAQ:ISIS, NASDAQ:MDCO, NASDAQ:LGND
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
181.61B
PE Ratio
32.31
EPS
3.21
Volume (Avg. Vol.)
7.88M
Day's Range
$102.31 - $103.83
52-Week Range
$89.67 - $121.64
Dividend & Yield
$2.04 (1.97%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
Forget Cyber Monday: Buy These 17 Blue Chips Instead
Here's a list of 17 Blue Chip stocks we believe can sustain strong top and bottom line growth into the New Year, and rate a "Buy" for investors
Investing in Generation Y and the Next Great Baby Boom
Much like the Baby Boomers did more to shape the U.S. over the past 50 years, their children -- Generation Y -- will shape the next 50 years.
These 48 Blue Chips Are On the Move
It's time to review or gradings for 48 Blue Chip stocks in our portfolio
It May Be Time to Trim Away at Your Portfolio
The stock market is doing well for October, but its may be time to look through your portfolio in order to trim away some of the upcoming losers
Goldman Sachs Opens the Vault: 18 Companies Increasing Dividends
Abbott Laboratories (ABT) and Goldman Sachs (GS) led a big week of dividend increases that saw 18 companies pledge to toss more coin at investors.
Pedialyte Finds New Market Niche: Binge Drinking College Students
The trend has taken off as news has spread across social media outlets (and college newspapers) by students touting its effectiveness in lessening the impacts of heavy drinking the next morning.
5 Reasons I Own So Many Individual Dividend Paying Stocks
In the past month, I published the list of dividend holdings I own to my subscribers. Many subscribers were amazed at the number of companies I own; here's why
Google Bets on Healthcare — You Should, Too
Google is aiming at helping humans live longer via a new venture, Calico -- another nod at just how lucrative the healthcare space should continue to be.
Is the Baby Bust Finished?
America's decline in fertility appears to be leveling off, and a new boom could be just a couple years away. If so, what should investors be targeting?
3 Healthcare Stocks With Healthy Dividends
Protect yourself from the headwinds facing healthcare stocks by snatching up names that offer -- and are likely to keep offering -- big-time dividends.
3 ETFs For Dividend Marathon Runners
Looking for long-term dividends? These 3 ETFs focus on companies that have paid consistent dividends for the past five to 20 years.
30 ‘Magic Formula’ Stocks for July
The 'Magic Formula' stock screen has beaten the market consistently over recent years -- plenty of reason to consider these 30 companies for your own portfolio.
6 Reasons Most Dividend Investors Never Succeed
Buying dividend stocks and watching them throw off cash takes investing discipline. Here are 6 reasons retirement investors fail in the effort
75 Stock Ratings to Stay Ahead of the Eight Ball
Many investors take a break from the market during the summer. By doing so, they miss out on important trends. Here are 75 stock ratings to get you started.
What To Make Of Tuesday’s Surprising Market Move
Wall Street clearly made up for the shortened trading week with a broad rally on Tuesday. Here's our new research on 50 stocks in Portfolio Grader
Medical Device Stocks: Buy, Sell and Watch
Medtronic's Q4 earnings had medical device stocks buzzing this week. Take a look at which stocks to buy, sell and keep an eye on in the sector.
An HIV ‘Cure’? Let’s Not Overstate the Success
Merck, J&J and others won't be dropping their research to recreate the success seen in the early treatment of an HIV-positive child.
Newborn Cured of HIV
A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth.
